MedTrace Logo

Antibiotic PRophylAxis Based on infeCTIve Risk in Cardiac Implantable Electronic Device

NCT04736979 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1044

Last updated 2022-04-29

No results posted yet for this study

Summary

This study was aimed at the evaluation of a new protocol of antibiotic prophylaxis, stratified according to individual infective risk calculated with the Shariff score at the moment of cardiac implantable electronic device (CIED) implantation.

Conditions

  • Device Related Infection

Interventions

DRUG

amoxicillin clavulanate

dosage according to Shariff score and creatinine clearance

Sponsors & Collaborators

  • University Hospital of Ferrara

    lead OTHER

Principal Investigators

  • Matteo Bertini · Università degli Studi di Ferrara

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2020-08-31
Completion
2020-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04736979 on ClinicalTrials.gov